Global Autologous Matrix-induced Chondrogenesis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

utologous matrix-induced chondrogenesis (AMIC) is a 1-step cartilage restoration technique that combines microfracture with the use of an exogenous scaffold. Scope of the Report: This report focuses on the Autologous Matrix-induced Chondrogenesis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The functional principle of microfracturing is based on the release of multipotent mesenchymal progenitor cells, cytokines and growth factors from the subchondral bone.  The worldwide market for Autologous Matrix-induced Chondrogenesis is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 160 million US$ in 2023, from 100 million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers JRI Orthopaedics Ltd BioTissue Anika Therapeutics B. Braun Melsungen Arthro-Kinetics Geistlich Pharma CartiHeal Matricel Smith & Nephew Zimmer Biomet Holdings Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Hyaluronic Acid Collagen Polyethylene Glycol (PEG) Poly Lactic-Co-G ...
Table of Contents 1 Market Overview 1.1 Autologous Matrix-induced Chondrogenesis Introduction 1.2 Market Analysis by Type 1.2.1 Hyaluronic Acid 1.2.2 Collagen 1.2.3 Polyethylene Glycol (PEG) 1.2.4 Poly Lactic-Co-Glycolic Acid (PGLA) 1.3 Market Analysis by Applications 1.3.1 Knees Joint 1.3.2 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 It ...
5419

1247

OUR CLIENT